Barbara S. Jones

Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ.

Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Morgan, Lewis & Bockius LLP provides legal consulting services. It specializes in transactional, litigation, labor and employment, regulatory, and intellectual property legal services to various industries. The company was founded in 1873 and is headquartered in Philadelphia, PA.

Borel & Barbey is a law firm based in Geneva, Switzerland since 1907. With over sixty legal specialists, the firm provides services in various areas such as banking and finance, private clients, corporate, litigation and arbitration, family, real estate, tax, and labor. The firm is known for its strong values, including a high-quality relationship with its clients.

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million.

Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA.

Part of Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance is a leading research and healthcare organization dedicated to improving the lives of cancer patients. Seattle Cancer Care Alliance brings together top research teams and cancer specialists from Fred Hutch, Seattle Children's, and UW Medicine. Based in Seattle, WA, Seattle Cancer Care Alliance has nine clinical care sites in the region, including medical oncology clinics, hematology/medical oncology and infusion services, and radiation oncology clinics. Seattle Cancer Care Alliance was acquired by Fred Hutchinson Cancer Research Center on April 01, 2022. The company also has network affiliations with hospitals in five states. Founded in 1998, the company is committed to the pursuit of better, longer, and richer lives for their patients.

Part of Beazley Plc, Beazley USA Services, Inc. offers Cyber Services Snapshots that utilize the latest key data derived from incidents reported to Beazley. The American company enriches its data with threat intelligence and open-source data to pinpoint emerging cyber trends. Its Cyber Services team, underwriters, and claims experts offer actionable insights on key issues.

Part of Cancer Research Institute, Cancer Vaccine Acceleration Co. LLC is an alternative investment manager. The company is based in New York, NY.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.

Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA.

Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases.